José María Frade

José María Frade is a prominent researcher at the Cajal Institute of the Spanish National Research Council (CSIC) in Madrid, known for his groundbreaking work on the development of the nervous system in embryos. His innovative research on the role of the E2F4 transcription factor in neuron cell cycles has opened new avenues for understanding and potentially treating neurodegenerative diseases like Alzheimer's. Frade's insights led to the founding of Tetraneuron, a company that aims to develop a novel gene therapy targeting Alzheimer's by preventing the reactivation of neuronal cell cycles, thus preserving neuronal health.